This approach uses AlphaFold2 (an AI that predicts 3D protein shapes) not just to get one structure per protein, but to explore many plausible shapes of a drug target. These AI‑generated shapes are then used as ‘locks’ in large-scale virtual screening to find small‑molecule ‘keys’ (drug candidates) that fit, even when proteins flex or change shape.
Premium content - unlock to see the business problem analysis...
Premium content - unlock to see strategic analysis...
Executive brief, technical architecture, and market positioning for this use case.
Premium content...
Premium content...
Premium content...
Premium content...
Executive brief, technical architecture, and market positioning for this use case.
Premium content...
Premium content...
Executive brief, technical architecture, and market positioning for this use case.
5 use cases in this application